Know Labs Faces Delisting Concerns

TL;DR

KNOW stock is on the chopping block for delisting from NYSE American.

AI Summary

Know Labs, Inc. filed an 8-K on October 2, 2024, reporting a notice of delisting or failure to satisfy continued listing requirements. The company's common stock was previously suspended from trading on the NYSE American exchange, and this filing confirms the ongoing process related to its listing status.

Why It Matters

This filing indicates potential delisting from a major stock exchange, which could significantly impact the company's liquidity, investor confidence, and ability to raise capital.

Risk Assessment

Risk Level: high — The company has received a notice of delisting or failure to meet continued listing requirements, posing a significant risk to its stock's trading status.

Key Players & Entities

• KNOW LABS, INC. (company) — Registrant
• NYSE American (company) — Stock Exchange
• September 27, 2024 (date) — Earliest event reported
• October 2, 2024 (date) — Filing date

FAQ

Key Financial Figures

• $0.001 K — ch registered Common Stock, par value $0.001 KNW NYSE American LLC Indicate by chec
• $4.0 million — ide") requiring stockholders' equity of $4.0 million or more if the Company has reported los
• $6.0 million — f the four most recent fiscal years and $6.0 million or more if the Company has reported los
• $4.6 million — he Company had stockholders' deficit of $4.6 million and has had losses in the most recent f

Filing Documents

• knwn_8k.htm (8-K) — 29KB
• knwn_ex991.htm (EX-99.1) — 11KB
• knwn_ex991img1.jpg (GRAPHIC) — 4KB
• 0001654954-24-012655.txt ( ) — 173KB
• knwn-20240927.xsd (EX-101.SCH) — 6KB
• knwn-20240927_lab.xml (EX-101.LAB) — 14KB
• knwn-20240927_cal.xml (EX-101.CAL) — 1KB
• knwn-20240927_pre.xml (EX-101.PRE) — 9KB
• knwn-20240927_def.xml (EX-101.DEF) — 2KB
• knwn_8k_htm.xml (XML) — 4KB

01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On September 27, 2024, Know Labs, Inc. (the "Company") received a notification ("Letter") from the NYSE American LLC (the "NYSE American") stating that the Company is not in compliance with the minimum stockholders' equity requirements of Sections 1003(a)(ii) and 1003(a)(iii) of the NYSE American Company Guide (the "Company Guide") requiring stockholders' equity of $4.0 million or more if the Company has reported losses from continuing operations and/or net losses in three of the four most recent fiscal years and $6.0 million or more if the Company has reported losses from continuing operations and/or net losses in its five most recent fiscal years, respectively. As of June 30, 2024, the Company had stockholders' deficit of $4.6 million and has had losses in the most recent five fiscal years ended September 30, 2023. The Company is now subject to the procedures and requirements of Section 1009 of the Company Guide. The Company has until October 27, 2024, to submit a plan (the "Plan") of actions it has taken or will take to regain compliance with the continued listing standards by March 27, 2026. The Company intends to submit a plan to regain compliance with NYSE American listing standards. If the NYSE American accepts the Plan, the Company will be able to continue its listing during the Plan period and will be subject to periodic reviews including quarterly monitoring for compliance with the Plan until it has regained compliance. If the Plan is not accepted by the NYSE American, the Letter stated that delisting proceedings will commence. The Company may appeal a staff delisting determination in accordance with Section 1010 and Part 12 of the Company Guide. The Letter has no immediate effect on the listing or trading of the Company's common stock on the NYSE American. The Company's receipt of the Letter from the NYSE American does not affect the Company's

01 Other Events

Item 8.01 Other Events On October 2, 2024, the Company issued a press release announcing its receipt of the Letter. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated by reference herein.

Forward-Looking Statements

Forward-Looking Statements This report contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, but not limited to, statements that are based upon management's current expectations, assumptions, estimates, projections and beliefs. The use of words such as, but not limited to, "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "plan," "potential," "predict," "project," "should," "target," "will," or "would" and similar words or expressions are intended to identify forward-looking statements. These statements include, but are not limited to, statements regarding the impact of the Letter and the Company's ability to comply with the continued listing requirements of the NYSE American. These statements involve risks, uncertainties and other factors that may cause actual results or achievements to be materially different and adverse from those expressed in or implied by the forward-looking statements. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. Other risks relating to the Company's business, including risks that could cause results to differ materially from those projected in the forward-looking statements in this report, are detailed in the Company's latest Form 10-K filing with the Securities and Exchange Commission, especially under the heading "Risk Factors." The forward-looking statements in this report speak only as of this date, and the Company disclaims any intent or obligation to revise or update publicly any forward-looking statement except as required by law. - 2 -

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits . Exhibit No. Description 99.1 Press Release, dated October 2, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) - 3 -

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 2, 2024 KNOW LABS, INC. /s/ Ronald P. Erickson Name: Ronald P. Erickson Title: Chairman of the Board - 4 -

View Full Filing

View this 8-K filing on SEC EDGAR